International Journal of Infectious Diseases
Volume 14, Issue 1 , Pages e50-e54, January 2010

Increased serum ferritin levels in patients with Crimean-Congo hemorrhagic fever: can it be a new severity criterion?

  • Sener Barut

      Affiliations

    • Department of Infectious Diseases and Clinical Microbiology, Gaziosmanpasa University, 60100 Tokat, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90 356 212 9500/1207; fax: +90 356 213 3179.
  • ,
  • Fatma Dincer

      Affiliations

    • Intensive Care Unit, Cevdet Aykan State Hospital, Tokat, Turkey
  • ,
  • Idris Sahin

      Affiliations

    • Department of Internal Medicine, Inonu University, Malatya, Turkey
  • ,
  • Huseyin Ozyurt

      Affiliations

    • Department of Biochemistry, Gaziosmanpasa University, Tokat, Turkey
  • ,
  • Mehmet Akkus

      Affiliations

    • Infectious Diseases Clinic, Cevdet Aykan State Hospital, Tokat, Turkey
  • ,
  • Unal Erkorkmaz

      Affiliations

    • Department of Biostatistics, Gaziosmanpasa University, Tokat, Turkey

Received 27 February 2008; received in revised form 6 November 2008; accepted 10 March 2009. published online 01 June 2009.

Corresponding Editor: William Cameron, Ottawa, Canada

Summary 

Objectives

Serum ferritin is one of the markers indicating hemophagocytosis that may have a role in the pathogenesis of Crimean-Congo hemorrhagic fever (CCHF). This study was designed to determine any correlation between serum ferritin and routine diagnostic laboratory markers of CCHF, and to investigate the relationship between serum ferritin levels and disease severity.

Methods

Sixty-six patients with CCHF admitted to the hospital during the spring and summer months of 2006 and 2007 were included in the study. Serum ferritin levels were measured in sera obtained during the initial days of hospitalization. Data from 53 patients showing decreasing platelet counts over the first three days were used for further analysis and these patients were divided into two groups according to disease severity: group A included severe cases with lowest platelet counts ≤20×109/l and group B included mild cases with lowest platelet counts >20×109/l.

Results

Forty patients (60.6%) were male (mean age 43±17 years). Three patients died, thus the fatality rate was 4.5%. Fifty-one patients (77.3%) had abnormal serum ferritin levels, with levels above 500 ng/ml in 62.1%. There was a significant negative correlation between ferritin levels and concordant platelet counts (p<0.001; r=−0.416) and ferritin was also found to be positively correlated with aspartate aminotransferase (p<0.001; r=0.625), alanine aminotransferase (p<0.001; r=0.479), and lactate dehydrogenase (p<0.001; r=0.684). Group A had higher ferritin levels than group B (p < 0.001). Receiver operating characteristic analysis revealed that a ferritin level of ≥1862ng/ml had a sensitivity of 87.5% and a specificity of 83.8% in differentiating severe cases from mild ones.

Conclusions

Increased serum ferritin levels may suggest a significant role of hemophagocytosis in the pathogenesis of CCHF and may be a useful marker for diagnosis, disease activity, and prognosis.

Keywords: Crimean-Congo hemorrhagic fever, Ferritin, Hemophagocytosis, Platelet count

 

PII: S1201-9712(09)00144-1

doi:10.1016/j.ijid.2009.03.009

International Journal of Infectious Diseases
Volume 14, Issue 1 , Pages e50-e54, January 2010